Valo Health
Boston
About Valo Health
Valo Health, Inc (Valo) is a technology company focused on utilizing large scale data and AI-driven computation to discover and develop therapeutics. Valo aims to fully integrate human-centric data across the entire drug development life cycle into a single unified architecture, thereby accelerating the discovery and development of life-changing drugs while simultaneously reducing costs, time, and failure rates. The company’s Opal Computational Platform™ is an end-to-end drug discovery and development platform with a unified architecture designed to transform data into valuable insights that may accelerate discoveries and enable Valo to advance a robust pipeline of programs, initially focused on cardiovascular metabolic renal, oncology, and neurodegenerative disease. Founded by Flagship Pioneering and headquartered in Boston, MA, Valo also has offices in Lexington, MA, and New York, NY. To learn more, visit valohealth.com.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 101 – 250
- Estimated revenue: $100K – $500K
- Total funding: $460.0M
- Funding stage: Late Stage Venture
- Last round: Series C (Oct 2022)
- Website: valohealth.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Care, Information Technology, Medical
Social Profiles
Canonical: https://fsome.com/organization/valo-health-55076 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.